Laurie Toich, Assistant Editor

CMS seeks to aid states in creation of high-risk pools and state-operated reinsurance programs.

New tool would help states apply for Section 1322 waivers.

FDA issues safety warning for canagliflozin in the treatment of type 2 diabetes.

Canagliflozin (Invokana) may increase the risk of leg and foot amputations in patients with type 2 diabetes.

Top news of the day from across the healthcare landscape.

Breast cancer incidence has climbed among Asian Americans, while diagnosis rates among other groups have trended downward.

New study questions the benefits of medical marijuana laws.

Substantial increase in breast cancer incidences among Koreans, South Asians, and Southeast Asians.

Top news of the day from across the healthcare landscape.

Nearly half of elderly patients were inappropriately prescribed an antibiotic.

Thalamus plays a larger role in memory than previously thought.

After 3 days, patients treated with methadone during surgery no longer required opioids.

The World Health Organization recently announced plans to launch a pilot program for prequalifying biosimilars.

Top news of the day from across the healthcare landscape.

Express Scripts partnership seeks to improve prescription drug savings.

Postbiotics observed to reduce blood glucose levels and increase insulin sensitivity in patients with diabetes.

Top news of the day from across the healthcare landscape.

The cost of branded, specialty, and generic drugs increased 8.77% in 2016.

The cost of prescription drugs has grown significantly over the past few years.

No difference in safety or efficacy between bevacizumab (Avastin) and aflibercept (Eylea).

Obesity-related mortality nearly twice the rate of tobacco-related deaths.

Top news of the day from across the healthcare landscape.

World Health Organization plans to launch a biosimilar prequalification program.

Metabolism of synthetic cannabinoids could lead to dangerous adverse events.

Top news of the day from across the healthcare landscape.

Diet soda may not actually be a healthier alternative to beverages high in sugar.

Avelumab (Bavenico) approved for advanced or metastatic urothelial carcinoma.

Avelumab (Bavencio) treats advanced or metastatic urothelial carcinoma that advanced during or after platinum-containing chemotherapy or within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.

Kisqali Femara Co-Pack only requires 1 co-payment.

Kisqali Femara Co-Pack (ribociclib tablets; letrozole tablets) treats hormone receptor-positive, human epidermal growth factor receptor-2 negative breast cancer in post-menopausal patients.